Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 47.5 | 50 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 44.0 | 48 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 54.0 | 46 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 52.0 | 51 | |
N2586 | IL-1 alpha | 100 | ng/mL | 1 | PDGF-BB | 45.0 | 53 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 21.0 | 41 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 25.5 | 64 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 26.5 | 62 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 22.0 | 54 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 21.5 | 64 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 23.5 | 68 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 24.0 | 43 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 21.0 | 54 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 38.5 | 72 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 37.0 | 37 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 40.0 | 42 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 47.0 | 51 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 41.0 | 51 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 48.0 | 46 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 39.0 | 68 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | PDGF-BB | 41.0 | 39 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | PDGF-BB | 24.0 | 64 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | PDGF-BB | 22.0 | 51 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | PDGF-BB | 25.0 | 86 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | PDGF-BB | 23.0 | 59 |